RenovoRx, Inc.
RNXT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001574094
No open-market purchases or sales by RenovoRx, Inc. insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $9.00M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding RenovoRx, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 31 | 28 | −3 |
| Shares | 8.56M | 9.20M | +633.2K (+7.4%) |
| Value | $8.58M | $9.00M | +$419.3K (+4.9%) |
New holders (3)
Institutions that held RenovoRx, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Clear Creek Financial Management, LLC | 29,058 | $28.5K | 0.00% |
| Barclays PLC | 1,151 | $1.13K | 0.00% |
| SBI Securities Co., Ltd. | 700 | $686 | 0.00% |
Sold out (6)
Institutions that held RenovoRx, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Nixon Peabody Trust Co | 97,165 | $98.1K |
| HRT Financial LP | 43,120 | $43.0K |
| Cypress Point Wealth Management, LLC | 20,000 | $20.2K |
| StoneX Group Inc. | 12,728 | $12.9K |
| Colony Group, LLC | 11,000 | $11.1K |
| Citigroup Inc | 3,917 | $3.96K |